Between 1986 and 2003, 43 eligible patients were identified, 29 female and 14 male, ranging in age from 32 years to 88 years at the time of diagnosis. The majority of patients were aged between 50 and ...
At week 52 in a randomized, controlled trial, results suggest that tocilizumab is more effective than methotrexate in ...
Long-term flare risk and remission rates did not differ between patients with well-controlled RA who tapered vs continued MTX therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback